Intrinsic Value
Viracta Therapeutics, Inc. (VIRX)
$0.8478
-0.03 (-3.66%)
| Enterprise Value | -2.70 |
|---|---|
| Net Debt | 13.24 |
| Equity Value | -15.94 |
| Shares Outstanding | 38.62 |
| Equity Value Per Share | -0.41 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt